Confidentiality during drug registration in Singapore is maintained through strict regulatory frameworks. The Health Sciences Authority (HSA) enforces data protection protocols, ensuring sensitive information is accessible only to authorized personnel. Secure electronic submission systems and confidentiality agreements further safeguard proprietary data, preventing unauthorized disclosure throughout the evaluation and approval process.